FCF co-organizes, together with its partner YAFO Capital, the “ACCESS CHINA Biotech Forum – Summer Showcase” which will be held online on June 9th-18th, 2021.
The largest China oriented healthcare partnering event – We are honored to invite you to our “ACCESS CHINA Biotech Forum @ Bio Convention Week 2021”， which will take place between June 9th and 18th, 2021. The Summer event expects to host 100+ company presentations, 10 keynote speeches, and 1,000+ global participants during Bio Convention Week.
Effective partnering and China market assessment platform – ACCESS CHINA is the most effective deal-making platform for pharma and biotech leaders looking to enter in the Chinese market. We provide direct opportunities connecting the right partners for development, licensing, financing and commercial collaborations.
Company roadshows are divided into 4 sessions:
1. Global Out-Licensing Session
Global pharmas looking for out-licensing opportunities in China
2. China Biotech Out-Licensing Session
Chinese biotech looking for global out-licensing & partnering opportunities
3. China Asset M&A Session
Chinese pharmas looking for domestic M&A and out-licensing opportunities
4. China Biotech Fundraising Session
China Biotech Fundraising Session
We look forward to welcoming you at our summer event in June!
ACCESS CHINA Forum Organizing Committee
Summer Showcase Tentative Agenda
|Cross-border sessions||China Domestic sessions||Replay (VoD)|
|9:30-11:30 am||ET (9:30-11:30 pm, Day-1)||Global Out-Licensing Session (US/Canada)||China Asset M&A & Licensing Session|
|3:00-5:00 pm||CET (9:00-11:00am)||Global Out-Licensing Session (EU & APAC)||Biotech Fundraising Session|
|9:00-11:00pm||ET (9:00-11:00 am)
CET (3:00 -5:00pm)
|China Biotech OutLicensing Session|
Who should present ?
Global pharma/biotech companies:
- Looking for out-licensing opportunities in China
- With clinical stage pharmaceutical assets
- Focusing on Oncology, CNS, Cardiovascular, Ophthalmology, Orthopedics, Pediatrics, GI, and other therapeutic areas
Chinese pharma/biotech companies:
- Looking for out-licensing opportunities in China or worldwide
- Looking for equity investment opportunities in China
Who are the attendees ?
- BD and C-level executives from Chinese pharma/biotech companies looking for inlicensing opportunities to enrich pipeline (Global Out-licensing session; China M&A & Licensing session)
- BD and C-level executives from pharma/biotechs outside China looking for in-licensing opportunities to enrich pipeline in China and other regions (Global Out-licensing session; China Biotech Innovation & Out-licensing session)
- VCs and PEs looking for pharma/biotech investment opportunities(Biotech Fundraising session)
Why CHINA ?
Licensing has become one of the fastest growing strategies by Chinese pharmas China related licensing transactions significantly increased despite of COVID-19 in 2020. There were in total 129 China related cross border licensing deals including 36 outlicensing deals and 93 in-licensing deals, representing an increase of 59% YoY.
Why ACCESS CHINA Platform ?
- Broader Chinese Strategic Company & Investor Coverage
Compared to other conferences such as Bio Convention or Bio Showcase, ACCESS CHINA has the broadest coverage of Chinese strategic companies and investors who are looking for in/out licensing opportunities.
- Easier China Market Assessment
We gather interests for presenting companies within two weeks after the presentations, an easy and effective way to assess the level of interest in the Chinese market
- More Exposure via Different Channels
ACCESS CHINA promotes presenting companies through various channels including asset listing on platform, video roadshow on live day and on demand, asset report distribution to our members, and promoting to targeted investors through email and social media.
Apply to present @ ACCESS CHINA
To apply for a “Presenting Slot”, you simply need to submit the application form accessible via the link below. Once approved by AC Forum Organizing Committee, you will be offered to present at ACCESS CHINA Forum. Presenting slots are based on a first come, first serve basis.
ACCESS CHINA Online Partnering Day
Presentation Submission & Review
|Company submits application form with partnering objectives (licensing, capital raising, M&A, etc)|
|ACCESS CHINA Committee will review the opportunity in the related therapeutic areas and accept the application.|
|YAFO Life Science banking team will help you to prepare and coordinate for the conference day.|
|Company will present either via recording presentation or live presentation (please let us know your preference in the application xls form). Presentation replay will be organized 7 days afterwards.|
|After the conference, YAFO will collect interests and feedbacks from Chinese investors and provide an “investor list name” the presenting company. (free of charge)|
Customized exposure & Deal Closing
|YAFO will expose Company to a larger and customized list based on our investor base in related therapeutic area (for engaged clients only).|
|Facilitate the signing of LOI/Term Sheet, Due Diligence, and closing of the transaction.|
JOIN US WHEN YOU ARE READY
For Global Biopharma Companies
No need to wait for months to spend time and money for a physical event in China. As ACCESS CHINA has several Online Partnering Day events through the year, you are welcome to join us when you are ready.
For Chinese Biopharma Companies
ACCESS CHINA has strong coverage of pharmaceutical and biotech companies from North America, Europe, MENA and APAC regions. This offers you an ideal channel to meet with potential outlicensing or commercial partners in different regions.
To apply for roadshow slots, attendance, sponsoring, and media support, please contact: